First published online August 18, 2004
Development 131, 1706e (2004)
© The Company of Biologists Limited
New anticancer therapeutic: a Legless target?
Many colorectal cancers are caused by disrupted Wnt signalling. During
normal Wnt signalling, activation of the pathway inhibits the Adenomatous
Polyposis Coli (APC) complex, allowing ß-catenin to accumulate and
associate with Legless (Lgs) and TCF DNA-binding proteins, leading to the
expression of target genes. In 80% of cases of colorectal cancer, APC is
inactivated, causing an increase in ß-catenin levels and constitutive
gene activation. Hoffmans and Basler
(p. 4393) reasoned
that specific interference of the ß-catenin/Lgs association would prevent
constitutive gene activation and halt the progression of cancer, and they use
Drosophila to investigate this potential drug target. They show that
the association between Lgs and ß-catenin (Armadillo in
Drosophila) is dependent on two of the acidic amino acid residues in
Armadillo. This putative contact site is highly specific to Lgs, and its
disruption severely reduces Wnt-activated gene expression. The researchers
conclude that the ß-catenin/Lgs interaction could be a target for
therapeutic intervention.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in Development:
- Identification and in vivo role of the Armadillo-Legless interaction
- Raymond Hoffmans and Konrad Basler
Development 2004 131: 4393-4400.
[Abstract]
[Full Text]